Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extrafine versus coarse-particle inhaled corticosteroids in smokers and ex-smokers with asthma
NL-OMON38937Phase 3Withdrawn
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of beclomethasone and fluticasone in asthma and asthmatic bronchitis (3 arms), sponsored by University Medical Center Groningen. Primary endpoints: PD20 small particle adenosine and Peripheral airway resistance (R5-R20) at PD20. Planned start Mar 2013; status: withdrawn.
02
Drugs
beclomethasonefluticasone
03
Conditions
asthmaasthmatic bronchitis
Beyond the preview
Go deeper on NL-OMON38937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38937.